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Abstract We sought to determine the inﬂuence of single-
nucleotide polymorphisms (SNPs) in RANKL, RANK, and
OPG on volumetric bone mineral density (vBMD) and bone
geometry at the radius in men. Pairwise tag SNPs (r
2 C 0.8)
for RANKL (n = 8), RANK (n = 44), and OPG (n = 22)
and ﬁve SNPs near RANKL and OPG strongly associated
with areal BMD in genomewide association studies were
previously genotyped in men aged 40–79 years in the
European Male Ageing Study (EMAS). Here, these SNPs
were analyzed in a subsample of men (n = 589) who had
peripheral quantitative computed tomography (pQCT)
performed at the distal (4%) and mid-shaft (50%) radius.
Estimated parameters were total and trabecular vBMD (mg/
mm
3) and cross-sectional area (mm
2) at the 4% site and
cortical vBMD (mg/mm
3); total, cortical, and medullary
area (mm
2); cortical thickness (mm); and stress strain index
(SSI) (mm
3) at the 50% site. We identiﬁed 12 OPG SNPs
associated with vBMD and/or geometric parameters,
including rs10505348 associated with total vBMD (b [95%
CI] = 9.35 [2.12–16.58], P = 0.011), cortical vBMD
(b [95% CI] = 5.62 [2.10–9.14], P = 0.002), cortical
thickness (b [95% CI] = 0.08 [0.03–0.13], P = 0.002), and
medullary area (b [95% CI] =- 2.90 [-4.94 to -0.86],
P = 0.005) and rs2073618 associated with cortical vBMD
(b [95% CI] =- 4.30 [-7.78 to -0.82], P = 0.015) and
cortical thickness (b [95% CI] =- 0.08 [-0.13 to -0.03],
P = 0.001). Three RANK SNPs were associated with
vBMD, including rs12956925 associated with trabecular
vBMD (b [95% CI] =- 7.58 [-14.01 to -1.15],
P = 0.021). There were ﬁve RANK SNPs associated with
geometric parameters, including rs8083511 associated with
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DOI 10.1007/s00223-011-9532-ydistal radius cross-sectional area (b [95% CI] = 8.90
[0.92–16.88], P = 0.029). No signiﬁcant association was
observed between RANKLSNPs and pQCT parameters. Our
ﬁndings suggest that genetic variation in OPG and RANK
inﬂuences radius vBMD and geometry in men.
Keywords Osteoporosis   Genetic association   Genetic
polymorphism   Male   QCT
Introduction
Areal bone mineral density (BMDa) as determined by dual-
energy X-ray absorptiometry (DXA) is an important
determinant of future fracture risk [1, 2]. However, other
factors, including bone size and shape, also inﬂuence bone
strength and susceptibility to fracture [3, 4]. Lower bone
width, cortical area, and thickness as measured by DXA at
both axial and peripheral skeletal sites have been associ-
ated with higher risk of fragility fractures [5]. Quantitative
computed tomography (QCT) provides additional infor-
mation on bone compartments, including volumetric bone
mineral density (vBMD) at both predominantly cortical
and trabecular sites, and geometric parameters of bone,
including area, cortical thickness, and strength [6]. QCT
measurements can be made at both axial and appendicular
sites; the forearm is the most common appendicular site.
Previous studies have shown that radius vBMD and
geometry-based parameters are associated with risk of
fracture in both men [7] and women [8–11].
Genetic factors are known to inﬂuence both bone mass
and structure. Data from family and twin studies suggest
that genetic factors explain about 50% of variation in the
total radius and trabecular vBMD and up to 40% of cortical
vBMD [12, 13]. In addition, a large proportion of the
variation in geometric parameters such as radius cross-
sectional area (27%) and cortical thickness (51%) is
attributable to genetic factors [13].
The RANKL/RANK/OPG signaling pathway has a criti-
cal role in bone remodeling. Higher OPG plasma concen-
tration has been associated with higher femoral neck BMDa,
width, and strength [14]. Strong evidence of association has
previously been found between single-nucleotide polymor-
phisms (SNPs) within these genes and bone-related pheno-
types in both candidate gene studies [15] and genomewide
association studies (GWAS) [16–19]. Despite the critical
importance of the RANKL/RANK/OPG signaling path-
way, few studies have examined the association between
K. A. Ward   J. E. Adams
Clinical Radiology, Imaging Science and Biomedical
Engineering, The University of Manchester, Manchester
Academic Health Science Centre, Manchester, UK
e-mail: Kate.Ward@mrc-hnr.cam.ac.uk
J. E. Adams
e-mail: judith.adams@manchester.ac.uk
K. A. Ward
MRC-Human Nutrition Research, Cambridge, UK
S. Boonen
Leuven University Division of Geriatric Medicine, Katholieke
Universiteit Leuven, Leuven, Belgium
e-mail: steven.boonen@uz.kuleuven.ac.be
S. Boonen   D. Vanderschueren   H. Borghs
Leuven University Centre for Metabolic Bone Diseases,
Katholieke Universiteit Leuven, Leuven, Belgium
D. Vanderschueren
e-mail: dirk.vanderschueren@uz.kuleuven.ac.be
H. Borghs
e-mail: herman.borghs@uz.kuleuven.ac.be
D. Vanderschueren
Department of Andrology and Endocrinology, Katholieke
Universiteit Leuven, Leuven, Belgium
I. T. Huhtaniemi
Department of Surgery and Cancer,
Imperial College London, Hammersmith Campus, London, UK
e-mail: ilpo.huhtaniemi@imperial.ac.uk
G. Bartfai
Department of Obstetrics, Gynaecology and Andrology, Albert
Szent-Gyorgy Medical University, Szeged, Hungary
e-mail: bartfai@obgyn.szote.u-szeged.hu
F. F. Casanueva
Department of Medicine, Santiago de Compostela University,
Complejo Hospitalario Universitario de Santiago (CHUS),
CIBER de Fisiopatologı’a Obesidad y Nutricion (CB06/03),
Instituto Salud Carlos III, Santiago de Compostela, Spain
e-mail: felipe.casanueva@usc.es
G. Forti
Andrology Unit, Department of Clinical Physiopathology,
University of Florence, Florence, Italy
e-mail: g.forti@dfc.uniﬁ.it
A. Giwercman
Scanian Andrology Centre, Department of Urology, Malmo ¨
University Hospital, University of Lund, Lund, Sweden
e-mail: Aleksander.Giwercman@med.lu.se
T. S. Han   M. E. Lean
Department of Human Nutrition, University of Glasgow,
Glasgow, UK
e-mail: t.s.han@doctors.org.uk
M. E. Lean
e-mail: mej.lean@clinmed.gla.ac.uk
K. Kula
Department of Andrology and Reproductive Endocrinology,
Medical University of Lodz, Lodz, Poland
e-mail: Krzysztof.Kula@csk.am.lodz.pl
D. Roshandel et al.: Polymorphisms in RANKL/RANK/OPG Signaling Pathway 447
123polymorphisms within genes in this pathway and either
vBMD or bone geometric parameters. Paternoster et al. [20]
investigated the association between four SNPs near
RANKL, RANK, and OPG strongly associated with lumbar
spine or hip BMDa in GWAS and tibial peripheral QCT
(pQCT) measures (both density and geometry) in young
European individuals. They observed signiﬁcant associa-
tions between OPG (rs4355801 and rs6993813) and RANK
(rs3018362)SNPsandcorticalvBMD.Recently,aGWASof
pQCT outcomes at the tibia has been published by the same
group.Inthisstudy,asingleSNP(rs1021188) inthe vicinity
of RANKL was associated with lower cortical vBMD at the
genomewide signiﬁcant level and less strongly with geo-
metric parameters.Itwasalsoassociatedwithhigherplasma
levels of soluble RANKL [21]. Yamada et al. [22] also
examinedtheassociationbetweenrs2073617andrs3134069
inOPGandvBMDinthedistalandproximalradiusin2,220
Japanese menand women andfoundsigniﬁcant associations
withradialvBMDinwomen.However,Yergesetal.[23,24]
found no associations between tagging and potentially
functional SNPs in RANKL, RANK, and OPG and vBMD at
the femoral neck and lumbar spine in 862 Caucasian men in
the Osteoporotic Fractures in Men (MrOS) study.
Here, we used data from the European Male Ageing
Study (EMAS), a population-based study of aging, to
determine whether SNPs in RANKL, RANK, and OPG are
associated with vBMD and bone geometric parameters at
the mid-shaft and distal radius in middle-aged and elderly
European men.
Materials and Methods
Study Participants
Men aged 40–79 years were recruited from population
registers in European centres, as described before [25].
Stratiﬁed sampling was used, with the target of recruiting
equal numbers of men in each of four 10-year age bands
(40–49, 50–59, 60–69, and 70–79 years). Subjects were
invited to participate by letter, and those who agreed were
asked to attend for a more comprehensive assessment
including a blood sample for genetic analysis. pQCT was
performed in a subsample of subjects in two centers
(Manchester, UK, and Leuven, Belgium). Participants were
subsequently excluded from the analysis if they reported
that at least one of their parents or grandparents was born
outside Europe or North America or if they reported use of
antiosteoporotic medications or systemic glucocorticoids.
Ethical approval in each center was obtained in accordance
with local practice and requirements, and subjects gave
informed consent.
pQCT
pQCT measurements were performed in the nondominant
radius using an XCT-2000 scanner (Stratec, Pforzheim,
Germany) in each center following the manufacturer’s
standard quality-assurance procedures. Total and trabecular
vBMD(mg/mm
3)andbonecross-sectionalarea(mm
2)were
measured at the distal radius (4%, voxel size 0.4 mm).
Cortical vBMD (mg/mm
3); total, cortical, and medullary
area (mm
2); cortical thickness (mm); and stress strain index
(SSI, mm
3) were measured at the mid-shaft radius (50%,
voxel size 0.6 mm). The detailed methodology for these
measurements has been described previously [26].
The European Forearm Phantom (EFP) was measured
for cross-calibration between the two centers; 10 repeat
measurements were taken in slices 1–4. The differences
were less than precision error for total, trabecular, and
cortical vBMD and for cortical area; therefore, no cross-
calibration was performed between the two centers.
The short-term precision values of two repeat mea-
surements with repositioning were as follows: total vBMD
2.1 and 1.3%; trabecular vBMD 1.27 and 1.42%; cortical
vBMD 0.77 and 0.71%; and cortical area 2.4 and 1.3% in
Manchester (n = 22) and Leuven (n = 40), respectively.
Genotype Data
Genotype data for pairwise tagging SNPs in RANKL
(receptor activator of NF-jB ligand, ofﬁcial gene symbol
TNFSF11)( n = 8), RANK (receptor activator of NF-jB,
ofﬁcial gene symbol TNFRSF11A)( n = 44), and OPG
(osteoprotegerin, ofﬁcial gene symbol TNFRSF11B)
(n = 22) and for additional OPG (n = 3) and RANKL
(n = 2) SNPs associated with BMDa in GWAS were
generated in EMAS as previously described. These SNPs
were previously tested for association with markers of bone
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123turnover, calcaneal quantitative ultrasound parameters, and
BMDa at the lumbar spine and total hip as measured by
DXA in this cohort [15].
Statistical Analysis
Linear regression under an additive genetic model was
used to test for association between SNPs and the outcome
variables, adjusting for center using PLINK (1.05) [27].
Signiﬁcant results were further adjusted for age, weight,
and height. The results are reported as the change in the
mean of the outcome variable (b coefﬁcient) for each copy
of the minor allele with 95% conﬁdence intervals (CIs). For
signiﬁcant associations, the interaction between SNP and
center was tested to determine if there was any between-
center heterogeneity using STATA (9.2; StataCorp LP,
4905 Lakeway Drive, College Station, TX).
Assuming a 0.05 type I error, minor allele frequencies
(MAFs) of 0.05–0.45, and 588 individuals, this study had
[80% power to detect differences of at least 0.4 SD
(MAF = 0.05) and 0.2 SD (MAF = 0.45) for all outcomes
underanadditivegeneticmodel.Thepowerofthestudywas
also calculated assuming a more conservative type I error of
0.0008 to take into account multiple testing, which was
calculated by dividing 0.05 by the number of independent
genotyped SNPs according to the method described by Li
and Ji [28]. With a 0.0008 type I error, the study had[80%
power todetect differences ofatleast 0.4 SD(MAF = 0.05)
and 0.3 SD (MAF = 0.45) for all outcomes. Statistical
power was calculated using Quanto v1.2.3 software [29].
Results
Subject Characteristics
In total, 589 men, mean (± SD) age 60 (± 11) years, were
included in the analysis. Characteristics of the pQCT
parameters are presented in Table 1.
Genetic Association Analysis
RANKL
We identiﬁed four RANKL tag SNPs (rs346588, rs9562414,
rs633137, and rs346574) associated with greater medullary
area at the mid-shaft radius. However, none of these
associations remained signiﬁcant after adjustment for age,
weight, and height (Supplementary Table 1).
There was no association between the two SNPs near
RANKL selected from GWAS (rs9594738 and rs9594759)
and pQCT outcomes.
RANK
We identiﬁed three RANK SNPs associated with vBMD:
rs9962159 associated with lower total vBMD, rs12956925
and rs4524035 associated with lower trabecular vBMD at
the distal radius. Four RANK SNPs (rs9951012, rs8083511,
rs6567276, and rs17665435) were associated with the
distal radius cross-sectional area. A single SNP,
rs12959396, was associated with both higher cortical
thickness and smaller medullary area at the mid-shaft
radius, but the association with medullary area did not
remain signiﬁcant after adjustment for age, weight, and
height (Table 2). Only modest linkage disequilibrium (LD)
exists between the associated SNPs, r
2 B 0.36.
There was no evidence of heterogeneity between centers
for SNP associations with pQCT parameters as tested by
SNP center interaction analysis.
In order to account for the number of independent SNPs
tested (n = 62), which was calculated by the method
described by Li and Ji [28], SNP associations would need
to reach a P value of \0.0008 to achieve statistical sig-
niﬁcance. None of the SNPs reached this level of
signiﬁcance.
OPG
We identiﬁed seven tag SNPs in OPG associated with total
and/or cortical vBMD: rs3134058 and rs3102724 associ-
ated with lower total vBMD at the distal radius; rs2073618,
rs3134057, and rs1032129 associated with lower cortical
vBMD at the mid-shaft radius; and rs10505348 and
rs2073617 associated with both total and cortical vBMD
(Table 3). There was a moderate to high LD (r
2[0.50)
between most of these SNPs (Fig. 1). The SNPs rs2073618
and rs3134058 (r
2 = 0.75) were also associated with lower
cortical thickness, and rs10505348 was associated with
both higher cortical thickness and smaller medullary area at
Table 1 pQCT parameters: mean and standard deviation (SD)
Variable n Mean SD
Distal radius
Total vBMD (mg/mm
3) 588 399.6 71.9
Trabecular vBMD (mg/mm
3) 588 203.6 43.0
Cross-sectional area (mm
2) 588 376.0 66.7
Midshaft radius
Cortical vBMD (mg/mm
3) 589 1,214.6 30.2
Cortical thickness (mm) 589 3.2 0.4
Total area (mm
2) 589 149.6 21.7
Cortical area (mm
2) 589 106.4 13.8
Medullary area (mm
2) 589 43.2 17.6
SSI (mm
3) 589 337.6 65.1
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123the mid-shaft radius. The tag SNP rs1032128 was only
associated with lower cortical thickness at the mid-shaft
radius. We also identiﬁed two tag SNPs in OPG, rs3102735
and rs4876868 (r
2 = 0.65), associated with higher SSI; but
the association between rs3102735 and SSI did not remain
signiﬁcant after adjustment for age, weight, and height
(Table 3).
All three SNPs near OPG selected from GWAS
(rs4355801, rs6469804, and rs6993813) were associated
with higher cortical vBMD at the mid-shaft radius, and
rs4355801 was also associated with SSI (Table 3). No
signiﬁcant association was observed between these SNPs
and the other pQCT outcomes.
There was no evidence of heterogeneity between centers
for SNP associations with pQCT parameters as tested by
SNP center interaction analysis.
None of the SNPs reached the level of signiﬁcance
required to correct for multiple testing (P\0.0008).
Discussion
To our knowledge, this study is the ﬁrst in which SNPs
within RANKL, RANK, and OPG have been tested for
association with bone vBMD and geometric parameters
measured by pQCT with good gene coverage. These results
are complementary to our previous analysis, which sug-
gested that SNPs within RANKL, RANK, and OPG inﬂu-
ence bone turnover and BMDa in this population of men
[15].
We found multiple SNPs in RANK and OPG associated
with radius geometry or vBMD (cortical, trabecular, and
total), with some SNPs associating with both. Some of
these SNPs were also associated with bone turnover and
BMDa in our previous study [15].
Multiple SNPs in RANK in low LD were associated with
total or trabecular vBMD or radius geometric parameters.
Two SNPs, rs6567276 and rs17665435, which were asso-
ciated with distal radius cross-sectional area, were also
associated with serum levels of N-terminal propeptide of
procollagen I (PINP) and C-terminal cross-linked telo-
peptide of collagen type I (CTX-I) bone turnover markers
in this population, as reported previously [15]. The asso-
ciation between rs6567276 and PINP was still signiﬁcant in
the pQCT subpopulation. The effect on distal radius cross-
sectional area was in the opposite direction to their effect
on bone turnover markers [15] (Table 3).
Eight tag SNPs in OPG were associated with vBMD
and/or cortical thickness, with some SNPs associating with
both and in the same direction; e.g., rs10505348 was
associated with higher vBMD (both total 4% site and
cortical 50% site) and cortical thickness. Some of the OPG
SNPs associated here with vBMD have previously been
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123associated with lumbar spine BMDa (with the same
direction of effect) in a large GWAS meta-analysis at the
genomewide signiﬁcant level (rs10505348, rs2073617, and
rs2073618) [17] and in this population as reported previ-
ously [15] (Table 3). Furthermore, rs2073617 [30, 31],
rs2073618 [31–38], and rs1032129 [39] have previously
been reported in association with lower BMDa measured
by DXA at different skeletal sites. As QCT measures of
BMD are not confounded by bone size, this provides evi-
dence that associations seen previously in OPG are truly
related to density. The SNP rs2073617 has also been
reported in association with lower vBMD measured by
pQCT at the proximal radius in Japanese premenopausal
women [22]. Most of the SNPs associated with vBMD and/
or cortical thickness in our current study were also asso-
ciated with bone turnover markers in this population, as
previously reported [15]. A number of these associations
remained signiﬁcant when the analysis was limited to the
subpopulation with pQCT. A lack of association with PINP
or CTX-I in the subpopulation may be due to the reduced
statistical power in the subpopulation; however, the effects
of SNPs on bone turnover were in the opposite direction
to their effects on vBMD and cortical thickness [15]
(Table 3).
The association between SNPs within OPG and serum
levels of OPG and soluble RANKL have been investigated
in a few studies [34, 37, 40]. Jorgensen et al. [40] did not
observe any signiﬁcant association between rs3102735,
which was associated with SSI in EMAS, and serum OPG
levels. Kim et al. [37] also did not observe any signiﬁcant
association between rs3102735 and rs2073618 and
between serum OPG and soluble RANKL. However, in the
Zhao et al. study [34], the Asn-Asn genotype of rs2073618
was associated with lower serum OPG levels compared to
the Lys-Lys genotype. This is consistent with our ﬁndings
in which the C allele (Asn) was associated with higher
bone turnover markers, lower BMD, and lower cortical
thickness. OPG acts as a decoy receptor and blocks
RANKL effects. RANKL increases the production, activ-
ity, and survival of osteoclasts [41]. Therefore, SNPs that
decrease the activity of OPG would be expected to have a
negative impact on bone health due to increased resorption.
All three SNPs near OPG selected from GWAS were
associated with higher cortical vBMD at the mid-shaft
radius. In a recent study of young (between 15 and
20 years) European individuals (1,492 males and 1,621
females from the Avon Longitudinal Study of Patents and
Children [ALSPAC] and 935 males from the Gothenburg
Osteoporosis and Obesity Determinants [GOOD] study),
rs6993813 and rs4355801 were associated with higher
cortical vBMD at the tibia [20].
Our ﬁndings contrast with those of Yerges et al. [23],
who investigated SNPs in RANKL, RANK, and OPG and
femoral neck (total, cortical, and trabecular) and lumbar
spine (total) vBMD. They did not observe any signiﬁcant
association between RANKL, RANK, and OPG SNPs and
Fig. 1 The LD pattern between
OPG (TNFRSF11B) SNPs
associated with pQCT
outcomes. SNP positions within
the gene and pairwise LD (black
r
2 = 1, white r
2 = 0) are shown
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123vBMD (total, cortical, or trabecular). The apparent dis-
crepant ﬁndings may relate to different sites of assessment.
In addition, their gene coverage for SNPs with MAF[5%
ranged from 1 to 100% per gene (64% on average);
therefore, they might not have genotyped the associating
SNPs [23, 24]. Our gene coverage for SNPs with
MAF[5% was[98%.
EMAS is a multicenter, population-based study; and
standard methods were used to minimize any variation
between centers. However, it has some limitations which
should be considered. As the response rate was about 39%,
those who declined to participate may have differed from
those who agreed to participate. Therefore, caution is
needed in interpreting the results, such as absolute values
of the phenotype data. However, considering that the main
analysis was based on a within-cohort analysis, it is unli-
kely that the main ﬁndings would be inﬂuenced by any
selection factors. False results might be produced due to
population substructure. There was no evidence of any
between-center heterogeneity, and the likelihood of popu-
lation stratiﬁcation was minimized by excluding subjects of
non-European ancestry. However, we were unable to use
methods such as genomic control or principal component
analysis to determine if there was any population sub-
structure as these methods need data on a large number of
SNPs. False-positive associations might be detected due to
multiple testing, whereas genuine associations might be
missed due to power constraints. Based on the method
described by Li and Ji [28], there were 62 independent
SNPs in RANKL (n = 8), RANK (n = 36), and OPG
(n = 18). Using Bonferroni correction to correct for mul-
tiple testing, the new cut-off for the P value will be 0.0008
(0.05/62 = 0.0008). None of the associations we found
here reached this level of signiﬁcance. Some of the SNPs
(i.e., in OPG) associated with radius vBMD in the present
study have, however, previously been associated with
lumbar spine BMDa in large-scale GWASs. A technical
limitation of pQCT measurement of cortical vBMD is the
inﬂuence of the partial volume effect, which is due to the
limited spatial resolution of pQCT. Therefore, some of the
associations with cortical vBMD may be in part due to
technical constraints: the thinner the cortices, the lower
vBMD. We tried to minimize technical artifacts by using a
higher threshold for analysis of cortical vBMD (960 mg/
cm
3) rather than the traditional 710 mg/cm
3 [42], to try to
reduce the partial volume effect.
To summarize, these ﬁndings add to our knowledge of
the possible inﬂuence of genetic variation in the RANKL/
RANK/OPG signaling pathway on bone and suggest that
SNPs in OPG and RANK affect radius vBMD and geom-
etry, especially cortical thickness, in men. The association
of OPG is more convincing as the results are consistent
with previous ﬁndings and SNPs are often associated with
multiple bone-related phenotypes. However, these ﬁndings
need to be validated in independent populations. If they are
conﬁrmed, ﬁne mapping and functional studies will be
needed to identify the causal variants.
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